Inventor · disambiguated record
Kevin Matthew Gardinier
Also filed as: GARDINIER KEVIN M · GARDINIER KEVIN MATTHEW
16 granted patents·6 pending applications·92 citations·filing 2002–2024
91Inventor score
Files withLILLY CO ELI9NOVARTIS AG6ARNOLD MACKLIN BRIAN2AMEGADZIE ALBERT K1AMEGADZIE ALBERT KUDZOVI1
Top patents by PatentIndex Score
22 records- 0190US11485742B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Nov 1, 2022·2 cites·22 claims
- 0289US11548865B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Jan 10, 2023·2 cites·29 claims
- 0386US7179804B2Tachykinin receptor antagonistsLILLY CO ELI·Filed 2003·Granted Feb 20, 2007·30 cites·18 claims
- 0485US7320994B2Triazole derivatives as tachykinin receptor antagonistsLILLY CO ELI·Filed 2003·Granted Jan 22, 2008·28 cites·34 claims
- 0583US7595339B2CB1 modulator compoundsLILLY CO ELI·Filed 2007·Granted Sep 29, 2009·6 cites·2 claims
- 0680US7902356B2Thiazolopyridinone derivates as MCH receptor antagonistsLILLY CO ELI·Filed 2005·Granted Mar 8, 2011·6 cites·11 claims
- 0778US7348359B2Retinoid X receptor modulatorsLILLY CO ELI·Filed 2002·Granted Mar 25, 2008·11 cites·37 claims
- 0877US2024140959A12-azaspiro[3.4]octane derivatives as m4 agonistsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0974US11820778B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Nov 21, 2023·0 cites·30 claims
- 1073US12421242B2Substituted tetrahydropyrrolo-pyridinone compounds and their use in treating medical conditionsKARUNA THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·0 cites·50 claims
- 1170US12122761B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Oct 22, 2024·0 cites·25 claims
- 1270US8263772B2MCH receptor antagonistsARNOLD MACKLIN BRIAN·Filed 2007·Granted Sep 11, 2012·2 cites·2 claims
- 1369US7276516B2CB1 antagonist compoundsLILLY CO ELI·Filed 2004·Granted Oct 2, 2007·5 cites·13 claims
- 1456US2024208953A1"Cyclopenta[c]pyrrol Negative Allosteric Modulators of NR2B"NOVARTIS AG·Filed 2022·Application pending·0 cites
- 1554US2008090860A1Retinoid x receptor modulatorsGARDINIER KEVIN M·Filed 2007·Application pending·0 cites
- 1646US8049013B25- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5H-thiazolo[5,4-C] pyridin-4-one derivatives and their use as MCH receptor antagonistsLILLY CO ELI·Filed 2007·Granted Nov 1, 2011·0 cites·16 claims
- 1744US2006160794A1Tachykinin receptor antagonistsAMEGADZIE ALBERT K·Filed 2004·Application pending·0 cites
- 1842US2004248913A1(Pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulatorsFiled 2002·Application pending·0 cites
- 1942US2012302547A1Novel mch receptor antagonistsARNOLD MACKLIN BRIAN·Filed 2012·Application pending·0 cites
- 2039US7838543B2MCH receptor antagonistsLILLY CO ELI·Filed 2005·Granted Nov 23, 2010·0 cites·10 claims
- 2137US8101764B2MCH receptor antagonistsAMEGADZIE ALBERT KUDZOVI·Filed 2007·Granted Jan 24, 2012·0 cites·14 claims
- 2233US9469632B26-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonistsLILLY CO ELI·Filed 2015·Granted Oct 18, 2016·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Kevin Matthew Gardinier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →